<DOC>
	<DOCNO>NCT02880189</DOCNO>
	<brief_summary>This study design investigate impact weight loss achieve IGB NASH early fibrosis select cohort patient obesity preselected high pre-test probability NASH early fibrosis base MRE-Hepatogram . In addition , study explore potential non-invasive imaging criterion NASH early fibrosis use EUS-Elastography .</brief_summary>
	<brief_title>EUS Guided Core Liver Biopsy IGB Placement Diagnosis Management NASH Obesity</brief_title>
	<detailed_description />
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<criteria>Patients diagnose Nonalcoholic Steatohepatitis early evidence fibrosis see MREhepatogram Referred clinically intragastric balloon placement weight loss Women pregnant plan pregnant breastfeed Previous history gastric surgery Current recent ( within 6 month ) gastric duodenal ulcer Gastroparesis Liver cirrhosis Coagulopathy active use coagulation Inability provide write informed consent</criteria>
	<gender>All</gender>
	<minimum_age>22 Years</minimum_age>
	<maximum_age>69 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Obesity NOS</keyword>
	<keyword>NASH</keyword>
	<keyword>NASH Fibrosis</keyword>
	<keyword>Intragastric Balloon</keyword>
	<keyword>ORBERA</keyword>
	<keyword>ORBERA Intragastric Balloon</keyword>
</DOC>